Advertisement
News
Advertisement

Misonix Announces New Distribution Agreement for Russia

Fri, 08/27/2010 - 9:32am
Bio-Medicine.Org

FARMINGDALE, N.Y., Aug. 27 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, has entered into a new, three year, exclusive distribution agreement with Martin-Medtechnika LLC, doing business as "EuroTech™."  Based in Moscow, Russia, "EuroTech" will distribute the SonaStar® Ultrasonic Surgical Aspirator, the BoneScalpel™ Ultrasonic Bone Cutter and the SonicOne® Ultrasonic Wound Debrider. The agreement provides "EuroTech" with the rights to sell throughout the Russian Federation and includes annual minimum purchase requirements.  Open market sales will commence after product registration with the Ministry of Health.

"EuroTech," which has a lengthy record of successful medical products distribution, is well known in Russia as a formidable competitor, building on a reputation as a distributor of state-of-the-art medical devices and capital equipment, with special emphasis on Neuro, Spine, Maxillo-facial and General Surgery.

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels.  In addition, OsteoSculpt™ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.  It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.

The SonicOne is an innovative, ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sp

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading